Physician profile
Ekong Uffort
NPI 1720240690
$17,683.20
in general payments reported to CMS, 2019-2025
7 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $608 · 2022: $43.80 · 2023: $13K · 2024: $4,484.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $14K · Travel and Lodging: $2,084 · Food and Beverage: $923 · Gift: $24.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $14,000.00 |
| Travel and Lodging | $2,083.71 |
| Food and Beverage | $923.20 |
| Gift | $24.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $17,505.07 | 2021-2024 | Davinci Xi, Da Vinci Surgical System |
| Boston Scientific Corporation | $71.32 | 2024 | Spyglass Discover |
| Organogenesis INC. | $26.11 | 2022 | |
| Kci USA, INC. | $25.15 | 2023 | Prevena |
| Smith+Nephew, INC. | $18.99 | 2021 | |
| Medtronic, INC. | $18.87 | 2024 | Signia |
| Tela Bio, INC. | $17.69 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ekong Uffort listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.